
### [NCIT:C7723](http://purl.obolibrary.org/obo/NCIT_C7723)
**Label:** Cardiac Sarcoma

**Subclasses:** [NCIT:C45759](http://purl.obolibrary.org/obo/NCIT_C45759) (Cardiac Rhabdomyosarcoma), [NCIT:C5363](http://purl.obolibrary.org/obo/NCIT_C5363) (Cardiac Kaposi Sarcoma), [NCIT:C5364](http://purl.obolibrary.org/obo/NCIT_C5364) (Cardiac Leiomyosarcoma), [NCIT:C45755](http://purl.obolibrary.org/obo/NCIT_C45755) (Cardiac Undifferentiated Pleomorphic Sarcoma), [NCIT:C5361](http://purl.obolibrary.org/obo/NCIT_C5361) (Cardiac Fibrosarcoma), 

**Class expressions from DL-Learner:**

- [UBERON:0004535](http://purl.obolibrary.org/obo/UBERON_0004535) (cardiovascular system) 53.57%
- Thing 53.00%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39079](http://purl.obolibrary.org/obo/NCIT_C39079) (Fc Epsilon Receptor I Signaling Pathway BioCarta))) 38.93%


